03/24/2025 | Press release | Distributed by Public on 03/24/2025 16:50
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Options (Right to buy) | (3) | 10/23/2032 | Common Stock | 18,983 | $21.41 | D | |
Options (Right to buy) | (4) | 04/14/2033 | Common Stock | 11,392 | $28.46 | D | |
Options (Right to buy) | (5) | 04/15/2034 | Common Stock | 115,314 | $4.46 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Zamore Denise C/O AGILON HEALTH, INC. 440 POLARIS PARKWAY, SUITE 550 WESTERVILLE, OH 43082 |
Chief Legal Officer |
/s/ Mimi Yang, as Attorney-in-Fact | 03/24/2025 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date. |
(2) | Includes restricted stock units. |
(3) | These options were granted on August 23, 2022, and vest in four equal installments on each anniversary of the grant date, subject to continued employment. |
(4) | These options were granted on April 14, 2023, and vest in four equal installments on each anniversary of the grant date, subject to continued employment. |
(5) | These options were granted on April 15, 2024, and vest in four equal installments on each anniversary of the grant date, subject to continued employment. |
Remarks: Exhibit List: Ex.24 - Power of Attorney |